Kepivance 66658-0113-03
Generic: Palifermin
- Manufacturer
- Swedish Orphan Biovitrum Ab (publ)
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- August 4, 2023
- Listing Expires
- December 31, 2026
- Application
- BLA125103
Need to source Kepivance? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Palifermin | 5.16 mg/1.2mL |
Drug Class
Mucocutaneous Epithelial Cell Growth Factor [EPC]Fibroblast Growth Factor 7 [CS]Increased Epithelial Proliferation [PE]
Selected Package
66658-0113-03Selected3 VIAL, SINGLE-USE in 1 CARTON (66658-113-03) / 1.2 mL in 1 VIAL, SINGLE-USE (66658-113-01)